<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">34270376</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>18</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>18</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2164-554X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>18</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
              <Day>31</Day>
            </PubDate>
          </JournalIssue>
          <Title>Human vaccines &amp; immunotherapeutics</Title>
          <ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>16</EndPage>
          <MedlinePgn>1-16</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2021.1935169</ELocationID>
        <Abstract>
          <AbstractText>Immunocompromised children are at increased risk of severe illness from vaccine-preventable infections. However, inadequate vaccine coverage remains a concern. This scoping review sought to determine the current state of knowledge regarding vaccine coverage of immunocompromised children. Bibliographic databases were searched for primary research from any year. Data were analyzed quantitatively and narratively. Ninety-seven studies met inclusion criteria. The most commonly studied vaccines were pneumococcal (<i>n</i> = 46), influenza (<i>n</i> = 44), diphtheria/tetanus/pertussis/poliomyelitis/<i>Haemophilus influenzae</i> type B/hepatitis B-containing (<i>n</i> = 36), and measles- and/or mumps- and/or rubella-containing (<i>n</i> = 29). Immunocompromising conditions studied included cancer/stem cell transplants (<i>n</i> = 24), solid organ transplants (<i>n</i> = 23), sickle cell disease (<i>n</i> = 21), immunosuppressive therapy (n = 14), human immunodeficiency virus (<i>n</i> = 12), splenectomy (<i>n</i> = 4), and primary immunodeficiency (<i>n</i> = 2). As more children are treated with immunosuppressive therapies, it is critical to identify whether they are being appropriately vaccinated for age and condition. We identified gaps in the current state of knowledge for specific vaccine types in specific immunocompromised populations.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>MacDonald</LastName>
            <ForeName>Shannon E</ForeName>
            <Initials>SE</Initials>
            <Identifier Source="ORCID">0000-0003-4675-4433</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Palichuk</LastName>
            <ForeName>Airlie</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Slater</LastName>
            <ForeName>Linda</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>John W. Scott Health Sciences Library, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Tripp</LastName>
            <ForeName>Hailey</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reifferscheid</LastName>
            <ForeName>Laura</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Nursing, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Burton</LastName>
            <ForeName>Catherine</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine and Dentistry, Department of Pediatrics, University of Alberta, Edmonton, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>07</Month>
          <Day>16</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Hum Vaccin Immunother</MedlineTA>
        <NlmUniqueID>101572652</NlmUniqueID>
        <ISSNLinking>2164-5515</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015721">Diphtheria-Tetanus-Pertussis Vaccine</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018073">Haemophilus Vaccines</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D022542">Measles-Mumps-Rubella Vaccine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015721" MajorTopicYN="N">Diphtheria-Tetanus-Pertussis Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018073" MajorTopicYN="Y">Haemophilus Vaccines</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008457" MajorTopicYN="Y">Measles</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D022542" MajorTopicYN="N">Measles-Mumps-Rubella Vaccine</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009107" MajorTopicYN="Y">Mumps</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014917" MajorTopicYN="Y">Whooping Cough</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Immunocompromise</Keyword>
        <Keyword MajorTopicYN="Y">coverage</Keyword>
        <Keyword MajorTopicYN="Y">immunization</Keyword>
        <Keyword MajorTopicYN="Y">immunodeficient</Keyword>
        <Keyword MajorTopicYN="Y">immunosuppress</Keyword>
        <Keyword MajorTopicYN="Y">vaccine</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>17</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>7</Month>
          <Day>16</Day>
          <Hour>17</Hour>
          <Minute>24</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34270376</ArticleId>
        <ArticleId IdType="pmc">PMC8920240</ArticleId>
        <ArticleId IdType="doi">10.1080/21645515.2021.1935169</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Esposito S, Prada E, Lelii M, Castellazzi L.. 
Immunization of children with secondary immunodeficiency. Hum Vaccines Immunother. 2015;11(11):2564–70. doi:10.1080/21645515.2015.1039208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1039208</ArticleId>
            <ArticleId IdType="pmc">PMC4685680</ArticleId>
            <ArticleId IdType="pubmed">26176360</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weber DJ, Rutala WA. Immunization of immunocompromised persons. Immunol Allergy Clin North Am. 2003;23(4):605–34. doi:10.1016/S0889-8561(03)00100-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0889-8561(03)00100-0</ArticleId>
            <ArticleId IdType="pubmed">14753383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldman AG, Beaty BL, Curtis D, Juarez-Colunga E, Kempe A. Incidence of hospitalization for vaccine-preventable infections in children following solid organ transplant and associated morbidity, mortality, and costs. JAMA Pediatrics. 2019;173(3):260–68. doi:10.1001/jamapediatrics.2018.4954.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2018.4954</ArticleId>
            <ArticleId IdType="pmc">PMC6439884</ArticleId>
            <ArticleId IdType="pubmed">30640369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Government of Canada . Page 8: Canadian Immunization Guide: part 3 - Vaccination of Specific Populations. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-8-immunization-immunocompromised-persons.html. Updated
2018. [accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Moore DL. Immunization of the immunocompromised child: key principles. Paediatrics &amp; Child Health. 2018;23(3):203–05. doi:10.1093/pch/pxx180.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pch/pxx180</ArticleId>
            <ArticleId IdType="pmc">PMC5951088</ArticleId>
            <ArticleId IdType="pubmed">29769807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Keyserling H, et al. Executive Summary: 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18. 2014. doi:10.1093/cid/cit816.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cit816</ArticleId>
            <ArticleId IdType="pubmed">24421306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Danziger‐Isakov L, Kumar D. Vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019;33(9):1-10. doi:10.1111/ctr.13563.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ctr.13563</ArticleId>
            <ArticleId IdType="pubmed">31002409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>American Academy of Pediatrics. Immunization in special circumstances. In Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL:
American Academy of Pediatrics. 2015: 68–101.</Citation>
        </Reference>
        <Reference>
          <Citation>Banerjee S, Dissanayake PV, Abeyagunawardena AS. Vaccinations in children on immunosuppressive medications for renal disease. Pediatr Nephrol. 2016;31(9):1437–48. doi:10.1007/s00467-015-3219-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-015-3219-y</ArticleId>
            <ArticleId IdType="pubmed">26450774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Donnell S, Dubé E, Tapiero B, Gagneur A, Doll MK, Quach C. Determinants of under-immunization and cumulative time spent under-immunized in a Quebec cohort. Vaccine. 2017;35(43):5924–31. doi:10.1016/j.vaccine.2017.08.072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2017.08.072</ArticleId>
            <ArticleId IdType="pubmed">28882440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol Theory Pract. 2005;8(1):19–32. doi:10.1080/1364557032000119616.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/1364557032000119616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacDonald SE, Russell ML, Liu XC, Simmonds KA, Lorenzetti DL, Sharpe H, Svenson J, Svenson LW. Are we speaking the same language? An argument for the consistent use of terminology and definitions for childhood vaccination indicators. Hum Vaccines Immunother. 2019;15(3):740–47. doi:10.1080/21645515.2018.1546526.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2018.1546526</ArticleId>
            <ArticleId IdType="pmc">PMC6605715</ArticleId>
            <ArticleId IdType="pubmed">30457475</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The Cochrane Community. About covidence. Published 
2019. https://community.cochrane.org/help/tools-and-software/covidence/about-covidence. [Accessed 2019 Jun 18]</Citation>
        </Reference>
        <Reference>
          <Citation>Hong QN, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, Dagenais P, Gagnon M, Griffiths F, Nicolau B, et al. Mixed Methods Appraisal Tool (MMAT), Version 2018 User Guide.; 2018. http://mixedmethodsappraisaltoolpublic.pbworks.com/. [accessed 2019 June 18]</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30905698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>The World Bank. World bank list of economies. Published . 2019. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. [Accessed 2019 June 18]</Citation>
        </Reference>
        <Reference>
          <Citation>European Centre for Disease Prevention and Control. Tuberculosis surveillance and monitoring in Europe 
2019. Published 2019.http://dx.publications.europa.eu/10.2900/512553. [Accessed 2020 Dec 15]</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2900/512553</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Prevention and Control. Measles cases and outbreaks. Published 
2020. https://www.cdc.gov/measles/cases-outbreaks.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>National Centre for Immunisation Research and Surveillance. Research to inform policy. Published 
2019. http://www.ncirs.org.au/our-work/research-inform-policy. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Typhoid vaccines: What you need to know. Published 
2019. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/typhoid.pdf. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Yellow fever vaccine: What you need to know. Published 
2019. https://www.cdc.gov/vaccines/hcp/vis/vis-statements/yf.pdf. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Government of Canada. Yellow fever. Published 
2019. https://www.canada.ca/en/public-health/services/diseases/yellow-fever.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Government of Canada. Typhoid vaccine: Canadian immunization guide. Published 
201. 9. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-23-typhoid-vaccine.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Government of Canada. Bacille calmette-guérin (BCG) vaccine. Published 
2014. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-2-bacille-calmette-guerin-vaccine.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Nelson NP
Chapter 4- travel-related infectious diseases - hepatitis A. Published
2020. https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/hepatitis-a. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Wakeham K, Kavanagh K. The burden of HPV-associated anogenital cancers. Curr Oncol Rep. 2014;16(9):402. doi:10.1007/s11912-014-0402-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11912-014-0402-4</ArticleId>
            <ArticleId IdType="pubmed">25118645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Diarrhea: Common illness, global killer. Published 
2015. https://www.cdc.gov/healthywater/pdf/global/programs/Globaldiarrhea508c.pdf. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Troeger C, Khalil IA, Rao PC, Cao S, Blacker BF, Ahmed T, Armah G, Bines JE, Brewer TG, Colombara DV, et al. Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years. JAMA Pediatrics. 2018;172(10):958–65. doi:10.1001/jamapediatrics.2018.1960.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2018.1960</ArticleId>
            <ArticleId IdType="pmc">PMC6233802</ArticleId>
            <ArticleId IdType="pubmed">30105384</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 influenza season. MMWR Recomm Reports. 2019;68:3. doi:10.15585/mmwr.rr6803a1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15585/mmwr.rr6803a1</ArticleId>
            <ArticleId IdType="pmc">PMC6713402</ArticleId>
            <ArticleId IdType="pubmed">31441906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. Altered immunocompetence - General best practice guidelines for immunization: Best practices guidance of the advisory committee on immunization practices (ACIP). Published 
2019. https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/immunocompetence.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Moore DL. Vaccine recommendations for children and youth for the 2018/2019 influenza season. Paediatrics &amp; Child Health. 2018;23(8):565. doi:10.1093/pch/pxy150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/pch/pxy150</ArticleId>
            <ArticleId IdType="pmc">PMC6241945</ArticleId>
            <ArticleId IdType="pubmed">31043846</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ojha RP, Tota JE, Offutt-Powell TN, Klosky JL, Minniear TD, Jackson BE, Gurney JG. Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers. PLoS One. 2013;8(8):e70349. doi:10.1371/journal.pone.0070349.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0070349</ArticleId>
            <ArticleId IdType="pmc">PMC3734301</ArticleId>
            <ArticleId IdType="pubmed">23940566</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Temkin SM, Seibel NL. Are we missing an opportunity for cancer prevention? Human papillomavirus vaccination for survivors of pediatric and young adult cancers. Cancer. 2015;121(19):3395–402. doi:10.1002/cncr.29515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cncr.29515</ArticleId>
            <ArticleId IdType="pubmed">26110510</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention . Rotavirus vaccination: what everyone should know. Published
2018. https://www.cdc.gov/vaccines/vpd/rotavirus/public/index.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Suresh S, Upton J, Green M, Pham‐Huy A, Posfay‐Barbe KM, Michaels MG, Top KA, Avitzur Y, Burton C, Chong PP, et al. Live vaccines after pediatric solid organ transplant: proceedings of a consensus meeting, 2018. Pediatr Transplant. 2019;23(7):e13571. doi:10.1111/petr.13571.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.13571</ArticleId>
            <ArticleId IdType="pubmed">31497926</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Booth C, Inusa B, Obaro SK. Infection in sickle cell disease: a review. Int J Infect Dis. 2010;14(1):e2-e12. doi:10.1016/j.ijid.2009.03.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijid.2009.03.010</ArticleId>
            <ArticleId IdType="pubmed">19497774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention . Complications and treatments of sickle cell disease. Published
2019. https://www.cdc.gov/ncbddd/sicklecell/treatments.html#Infection. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Belli AK, Dönmez C, Özcan Ö, Dere Ö, Dirgen Çaylak S, Dinç Elibol F, Yazkan C, Yilmaz N, Nazli O. Adherence to vaccination recommendations after traumatic splenic injury. Ulus Travma Ve Acil Cerrahi Derg. 2018;24(4):337–42. doi:10.5505/tjtes.2017.84584.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5505/tjtes.2017.84584</ArticleId>
            <ArticleId IdType="pubmed">30028492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Government of Canada . Page 7: Canadian immunization guide: part 3 - vaccination of specific populations. Published
2016. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-7-immunization-persons-with-chronic-diseases.html. [Accessed 2020 Dec 15]</Citation>
        </Reference>
        <Reference>
          <Citation>Bousvaros A, Lu Y. Immunizations in the child with inflammatory bowel disease. In Mamula P, Grossman A, Baldassano R, Kelsen J, Markowitz J, editors. Pediatric Inflammatory Bowel Diseaase. Cham, Switzerland: Springer; 2017. p. 663–68. doi:10.1007/978-3-319-49215-5_54.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-3-319-49215-5_54</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacDonald SE, Schopflocher DP, Golonka RP. The pot calling the kettle black: the extent and type of errors in a computerized immunization registry and by parent report. BMC Pediatr. 2014;14(1):1. doi:10.1186/1471-2431-14-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1471-2431-14-1</ArticleId>
            <ArticleId IdType="pmc">PMC3880846</ArticleId>
            <ArticleId IdType="pubmed">24387002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doganis D, Tsolia M, Dana H, Bouhoutsou D, Pourtsidis A, Baka M, Varvoutsi M, Servitzoglou M, Kosmidis H. Compliance with immunization against H1N1 influenza virus among children with cancer. Pediatr Hematol Oncol. 2013;30(2):149–53. doi:10.3109/08880018.2012.753961.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/08880018.2012.753961</ArticleId>
            <ArticleId IdType="pubmed">23301621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giannattasio A, Squeglia V, Lo VA, Russo M, Barbarino A, Carlomagno R, Guarino A. Pneumococcal and influenza vaccination rates and their determinants in children with chronic medical conditions. Italian Journal of Pediatrics. 2010;36(1):28. doi:10.1186/1824-7288-36-28.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1824-7288-36-28</ArticleId>
            <ArticleId IdType="pmc">PMC2851708</ArticleId>
            <ArticleId IdType="pubmed">20346141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Camerino M, Jackson S, Chinnakotla S, Verghese P. Effects of the influenza vaccine on pediatric kidney transplant outcomes. Pediatr Transplant. 2019;23(2):e13354. doi:10.1111/petr.13354.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.13354</ArticleId>
            <ArticleId IdType="pubmed">30714274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernández-Prada M, Rodríguez-Martínez M, García-García R, García-Corte MD, Martínez-Ortega C. Adapting immunisation schedules for children undergoing chemotherapy. Enferm Infecc Microbiol Clin. 2018;36(2):78–83. doi:10.1016/j.eimc.2016.09.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eimc.2016.09.003</ArticleId>
            <ArticleId IdType="pubmed">27773490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Esposito S, Marchisio P, Droghetti R, Lambertini L, Faelli N, Bosis, Tosi S, Begliatti E, Principi N. Influenza vaccination coverage among children with high-risk medical conditions. Vaccine. 2006;24(24):5251–55. doi:10.1016/j.vaccine.2006.03.059.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2006.03.059</ArticleId>
            <ArticleId IdType="pubmed">16621177</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carthon CE, Hall RC, Maxwell PR, Crowther BR. Impact of a pharmacist-led vaccine recommendation program for pediatric kidney transplant candidates. Pediatr Transplant. 2017;21(6):e12989. doi:10.1111/petr.12989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.12989</ArticleId>
            <ArticleId IdType="pubmed">28677269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wagner AL, Shrivastwa N, Potter RC, Lyon-callo SK, Boulton ML. Pneumococcal and meningococcal vaccination among Michigan children with sickle cell disease. J Pediatr. 2018;196:223–29. doi:10.1016/j.jpeds.2018.01.023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpeds.2018.01.023</ArticleId>
            <ArticleId IdType="pubmed">29555094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nero AC, Akuete K, Reeves SL, Dombkowski KJ. Pneumococcal vaccination rates in children with sickle cell disease. J Public Heal Manag Pract. 2014;20(6):587–90. doi:10.1097/PHH.0000000000000034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/PHH.0000000000000034</ArticleId>
            <ArticleId IdType="pubmed">24253403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Setse RW, Siberry GK, Moss WJ, Wheeling J, Bohannon BA, Dominguez KL. Meningococcal conjugate and tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccination among HIV-infected youth. Pediatr Infect Dis J. 2016;35(5):e152–e157S. doi:10.1097/INF.0000000000001078.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001078</ArticleId>
            <ArticleId IdType="pubmed">26855409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>de de la Fuente Garcia I, Coïc L, Leclerc J-M, Laverdière C, Rousseau C, Ovetchkine, Tapiéro B. Protection against vaccine preventable diseases in children treated for acute lymphoblastic leukemia. Pediatr Blood Cancer. 2017;64(2):315–20. doi:10.1002/pbc.26187.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.26187</ArticleId>
            <ArticleId IdType="pubmed">27718310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cecinati V, Esposito S, Schicchitano B, Delvecchio GC, Amato D, Pelucchi C, Jankovic M, De Mattia, Principi N. Effectiveness of recall systems for improving influenza vaccination coverage in children with oncohematological malignancies. Hum Vaccin. 2010;6(2):194–97. doi:10.4161/hv.6.2.10253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/hv.6.2.10253</ArticleId>
            <ArticleId IdType="pubmed">19946216</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen C-J, Bakeera-Kitaka S, Mupere E, Kasirye P, Munube D, Idro R, Hume H, Pfeffer B, LaRussa P, Green NS, et al. Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic. J Paediatr Child Health. 2019;55(7):795–801. doi:10.1111/jpc.14291.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jpc.14291</ArticleId>
            <ArticleId IdType="pmc">PMC6509021</ArticleId>
            <ArticleId IdType="pubmed">30411430</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong CI, Billett AL, Weng S, Eng K, Thakrar U, Davies KJ. A quality improvement initiative to increase and sustain influenza vaccination rates in pediatric oncology and stem cell transplant patients. Pediatr Qual Saf. 2018;3(1):e052. doi:10.1097/pq9.0000000000000052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/pq9.0000000000000052</ArticleId>
            <ArticleId IdType="pmc">PMC6132696</ArticleId>
            <ArticleId IdType="pubmed">30229188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cortina G, Ojinaga V, Zlamy M, Goner T, Riedl M, Rauchenzauner M, Entenmann A, Müller T. Vaccination status in pediatric solid-organ transplant recipients and their household members. Exp Clin Transplant. 2019;1(1):1–6. doi:10.6002/ect.2018.0184.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.6002/ect.2018.0184</ArticleId>
            <ArticleId IdType="pubmed">31050613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khemani K, Steele MK, Bakshi N, Krishnamurti L, Yildirim I. Vaccination adherence in pediatric patients post-hematopoietic stem cell transplant. Blood. 2018;132(Supplement1):3406. doi:10.1182/blood-2018-99-119283.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2018-99-119283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keeley NE, Cherven BO, Weinzierl E, Olson E, Thompson A, Mertens A, Haight AE. Re-Immunization Practices Among Survivors of Pediatric Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2011;17(2):S276. doi:10.1016/j.bbmt.2010.12.370.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbmt.2010.12.370</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mason KK, Becton D, Mack JM. Got polio? A QI project improving vaccinations rates in off-therapy cancer patients at Arkansas Children’s Hospital. J Investig Med. 2020;68:2. doi:10.1136/jim-2020-SRM.622.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jim-2020-SRM.622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crawford NW, Heath JA, Ashley D, Downie P, Buttery JP. Survivors of childhood cancer: an Australian audit of vaccination status after treatment. Pediatr Blood Cancer. 2010;54(1):128–33. doi:10.1002/pbc.22256.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.22256</ArticleId>
            <ArticleId IdType="pubmed">19785022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel SR, Bate J, Mathews R, Chisholm J, Heath PT. Vaccination status of children with cancer after completion of standard-dose chemotherapy and after haematopoietic stem cell transplant. Pediatr Blood Cancer. 2012;59(6):1116. doi:10.1002/pbc.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Volc SM, Almeida MTA, Abadi MD, Cornacchioni AL, Filho VO, Cristofani LM. Measles and rubella antibody status in children after treatment for acute lymphoblastic leukemia. J Pediatr (Rio J). 2006;82(6):481–84. doi:10.2223/JPED.1532.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2223/JPED.1532</ArticleId>
            <ArticleId IdType="pubmed">17003944</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marshall HS, McIntyref P, Richmond P, Buttery JP, Royle JA, Gold MS, Wood N, Elliott EJ, Zurynski Y, Toi CS, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J. 2013;32(5):530–37. doi:10.1097/INF.0b013e31827e92b7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e31827e92b7</ArticleId>
            <ArticleId IdType="pubmed">23249914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pettke A, Jocham S, Wiener A, Löcken A, Groenefeld J, Ahlmann M, Groll AH. Vaccination against influenza at a European pediatric cancer center: immunization rates and attitudes among staff, patients, and their families. Support Care Cancer. 2017;25(12):3815–22. doi:10.1007/s00520-017-3813-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00520-017-3813-6</ArticleId>
            <ArticleId IdType="pubmed">28733696</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tishler D, Escobedo E, Alhushki W, Margol AS, Mehta B, Rushing T. Influenza vaccine immunization in a pediatric oncology ambulatory practice. J Clin Oncol. 2013;31(31_suppl):139. doi:10.1200/jco.2013.31.31_suppl.139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/jco.2013.31.31_suppl.139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freedman JL, Reilly AF, Powell SC, Bailey LC. Quality improvement initiative to increase influenza vaccination in pediatric cancer patients. Pediatrics. 2015;135(2):e540–e546. doi:10.1542/peds.2014-0943.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2014-0943</ArticleId>
            <ArticleId IdType="pubmed">25583919</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olshefski RS, Bibart M, Frost R, Wood E, Hampl J, Mangum R, Ardura M, Guinipero T, Cripe TP. A multiyear quality improvement project to increase influenza vaccination in a pediatric oncology population undergoing active therapy. Pediatr Blood Cancer. 2018;65(9):e27268. doi:10.1002/pbc.27268.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.27268</ArticleId>
            <ArticleId IdType="pubmed">29856533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellino SM, Allen KE, Pleasant K, Keyes G, Poehling KA, Tooze JA. Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer. J Cancer Surviv. 2019;13(5):730–38. doi:10.1007/s11764-019-00791-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11764-019-00791-9</ArticleId>
            <ArticleId IdType="pmc">PMC6832771</ArticleId>
            <ArticleId IdType="pubmed">31342304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klosky JL, Hudson MM, Chen Y, Connelly JA, Wasilewski-Masker K, Sun C-L, Francisco L, Gustafson L, Russell KM, Sabbatini G, et al. Human papillomavirus vaccination rates in young cancer survivors. J Clin Oncol. 2017;35(31):3582–90. doi:10.1200/JCO.2017.74.1843.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1200/JCO.2017.74.1843</ArticleId>
            <ArticleId IdType="pmc">PMC5662846</ArticleId>
            <ArticleId IdType="pubmed">28837404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klosky JL, Russell KM, Canavera KE, Gammel HL, Foster RH, Parra GR, Simmons JL, Green DM, Hudson MM, et al. Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer. Cancer Prev Res. 2013;6(10):1101–10. doi:10.1158/1940-6207.CAPR-13-0127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1940-6207.CAPR-13-0127</ArticleId>
            <ArticleId IdType="pmc">PMC4264381</ArticleId>
            <ArticleId IdType="pubmed">23983087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klosky JL, Russell KM, Simmons JL, Foster RH, Peck K, Green DM, Hudson MM. Medical and sociodemographic factors associated with human papillomavirus (HPV) vaccination adherence among female survivors of childhood cancer. Pediatr Blood Cancer. 2015;62(9):1630–36. doi:10.1002/pbc.25539.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.25539</ArticleId>
            <ArticleId IdType="pmc">PMC4834844</ArticleId>
            <ArticleId IdType="pubmed">25900433</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Höcker B, Aguilar M, SchniHodgestzler P, Pape L, Webb NJA, Bald M, Genc G, Billing H, König J, et al. Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation. Pediatr Nephrol. 2018;33(2):341–50. doi:10.1007/s00467-017-3776-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00467-017-3776-3</ArticleId>
            <ArticleId IdType="pubmed">28983694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McGhee W, McHugh C, Mazariegos G, Squires R, Remaley L, Zetler K, Brown-Bakewell R, Green M, Michaels M. Improving immunization compliance in pediatric transplant candidates. Pediatr Transplant. 2017;21(Supplement 1):92–93. doi:10.1111/petr.12978.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.12978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thall TV, Rosh JR, Schwersenz AH, Eickmeyer, Fernandez M, Benkov KJ, LeLeiko NS. Primary immunization status in infants referred for liver transplantation. Transplant Proc. 1994;26:191.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8108936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Island E, Pearson A, Kaufman S, Fishbein T. Vaccination status in pediatric patients referred for liver transplantation. Am J Transplant. 2013; 13(Supplement 5): 249. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed11&amp;NEWS=N&amp;AN=71057295.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murray J, Wollersheim S, Yazigi N, Khan K, Kaufman S, Island E. Vaccination status of pediatric liver transplant candidates. Pediatr Transplant. 2015;19:120–21.</Citation>
        </Reference>
        <Reference>
          <Citation>Gonzalez B, Saracusa C. Barriers to vaccination of pediatric solid organ transplant candidates at a pediatric transplant center. Pediatr Transplant. 2017;21(Supplement 1):81–82. doi:10.1111/petr.12976.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.12976</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Urschel S, Cremer S, Birnbaum J, DallaPozza R, Fuchs A, Jäger G, Schmitz C, Belohradsky BH, Netz H. Lack of serologic immunity against vaccine-preventable diseases in children after thoracic transplantation. Transpl Int. 2009;23(6):619–27. doi:10.1111/j.1432-2277.2009.01030.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1432-2277.2009.01030.x</ArticleId>
            <ArticleId IdType="pubmed">20028497</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>L’Huillier AG, Wildhaber BE, Belli DC, Rodriguez M, Siegrist CA, Posfay-Barbe KM. Successful serology-based intervention to increase protection against vaccine-preventable diseases in liver-transplanted children: a 19-yr review of the Swiss national reference center. Pediatr Transplant. 2012;16(1):50–57. doi:10.1111/j.1399-3046.2011.01600.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-3046.2011.01600.x</ArticleId>
            <ArticleId IdType="pubmed">22093802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Sedaghat M, Alborzi A, Malek-Hosseini SA. Evaluation of immunity status to routine vaccination in pediatric liver transplant candidates. The Turkish Journal of Gastroenterology. 2015;25(1):26–31. doi:10.5152/tjg.2014.5139.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5152/tjg.2014.5139</ArticleId>
            <ArticleId IdType="pubmed">25910330</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Daniels H, Saracusa C, Worley S, Gonzalez B. Measles and varicella vaccination status and evidence of immunity during solid organ pre-transplantation evaluation. Am J Transplant. 2018;18(Supplement 4):739. doi:10.17159/2078-516x/2016/v28i5a1627.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.17159/2078-516x/2016/v28i5a1627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dehghani SM, Shakiba MA, Ziaeyan M, Imanieh MH, Haghighat M, Bahador A, Nikeghbalian S, Salahi H, Alborzi A, Malek-Hosseini SA, et al. Vaccination status in pediatric liver transplant candidates. Pediatr Transplant. 2009;13(7):820–22. doi:10.1111/j.1399-3046.2009.01177.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-3046.2009.01177.x</ArticleId>
            <ArticleId IdType="pubmed">19413722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chaves TSS, Pereira LM, Santos SDS, David-Neto E, Lopes MH. Evaluation of the vaccination status in pediatric renal transplant recipients. Pediatr Transplant. 2008;12(4):432–35. doi:10.1111/j.1399-3046.2007.00820.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-3046.2007.00820.x</ArticleId>
            <ArticleId IdType="pubmed">18466429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldman AG, Sundaram SS, Beaty BL, Torres R, Curtis D, Juarez-Colunga E, Kempe A. Immunization status at the time of liver transplant in children and adolescents. JAMA. 2019;322(18):1822–24. doi:10.1001/jama.2019.14386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2019.14386</ArticleId>
            <ArticleId IdType="pmc">PMC6865293</ArticleId>
            <ArticleId IdType="pubmed">31714979</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fela E, Rivard K, Pallotta A, Spinner M, Lepak M, Gonzalez BE. Pre-transplant vaccination adherence in pediatric solid organ transplant patients at a large academic medical center. Open Forum Infect Dis. 2018;5(suppl_1):S745–undefined. doi:10.1093/ofid/ofy210.2137.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ofid/ofy210.2137</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vo HD, Florescu DF, Brown CR, Chambers HE, Mercer DF, Vargas LM, Grant WJ, Langnas AN, Quiros-Tejeira RE. Invasive pneumococcal infections in pediatric liver-small bowel-pancreas transplant recipients. Pediatr Transplant. 2018;22(3):e13165. doi:10.1111/petr.13165.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/petr.13165</ArticleId>
            <ArticleId IdType="pubmed">29441651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Printza N, Farmaki E, Bosdou J, Gkogka C, Papachristou F. Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions. Hum Vaccin. 2010;6(10):819–22. doi:10.4161/hv.6.10.12846.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/hv.6.10.12846</ArticleId>
            <ArticleId IdType="pubmed">20930563</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bhagavatula M, Hawkins A, Inward C, Van Der, Van Der Voort J. Immunisation in renal transplantation –a joint audit. Arch Dis Child. 2012;97(Suppl 1):A159–A160. doi:10.1136/archdischild-2012-301885.374.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2012-301885.374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peleg N, Zevit N, Shamir R, Chodick G, Levy I. Seasonal influenza vaccination rates and reasons for non-vaccination in children with gastrointestinal disorders. Vaccine. 2015;33(1):182–86. doi:10.1016/j.vaccine.2014.10.086.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.10.086</ArticleId>
            <ArticleId IdType="pubmed">25444802</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Britto MT, Schoettker PJ, Pandzik GM, Weiland J, Mandel KE. Improving influenza immunisation for high-risk children and adolescents. Quality and Safety in Health Care. 2007;16(5):363–68. doi:10.1136/qshc.2006.019380.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/qshc.2006.019380</ArticleId>
            <ArticleId IdType="pmc">PMC2464966</ArticleId>
            <ArticleId IdType="pubmed">17913778</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Freiberg AS, Singleton AC. Adequacy of vaccine documentation against encapsulated bacteria in a population of children with sickle cell disease. Blood. 2011;118(21):4853. doi:10.1182/blood.V118.21.4853.4853.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood.V118.21.4853.4853</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gomes LMX, Reis TC, Vieira MM, de Andrade-Barbosa TL, Caldeira AP. Quality of assistance provided to children with sickle cell disease by primary healthcare services. Rev Bras Hematol Hemoter. 2011;33(4):277–82. doi:10.5581/1516-8484.20110077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5581/1516-8484.20110077</ArticleId>
            <ArticleId IdType="pmc">PMC3415769</ArticleId>
            <ArticleId IdType="pubmed">23049319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Moldes B, Carbajo AJ, Sánchez B, Fernández M, Garí M, Fernández MC, Álvarez J, García A, Cela E. Seguimiento en Atención Primaria de los recién nacidos con enfermedad falciforme detectados en el cribado neonatal de la Comunidad de Madrid. Anales De Pediatría. 2015;82(4):222–27. doi:10.1016/j.anpedi.2014.04.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.anpedi.2014.04.007</ArticleId>
            <ArticleId IdType="pubmed">24840253</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yé D, Kouéta F, Dao L, Kaboret S, Sawadogo A. [Pediatric management of sickle cell disease: experience at the Charles de Gaulle University Children’s Hospital in Ouagadougou (Burkina Faso)]. Sante. 2008;18(2):71–75. doi:10.1684/san.2008.0113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1684/san.2008.0113</ArticleId>
            <ArticleId IdType="pubmed">19188129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howard-Jones M, Randall L, Bailey-Squire B, Clayton J, Jackson N. An audit of immunisation status of sickle cell patients in Coventry, UK. J Clin Pathol. 2009;62(1):42–45. doi:10.1136/jcp.2008.058982.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jcp.2008.058982</ArticleId>
            <ArticleId IdType="pubmed">19103859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Infanti LM, Elder JJ, Franco K, Simms S, Statler VA, Raj A. Immunization adherence in children with sickle cell disease: a single-institution experience. J Pediatr Pharmacol Ther. 2020;25(1):39–46. doi:10.5863/1551-6776-25.1.39.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5863/1551-6776-25.1.39</ArticleId>
            <ArticleId IdType="pmc">PMC6938294</ArticleId>
            <ArticleId IdType="pubmed">31897074</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nofal R, Lorenzana A. Immunization rates in patients with sickle cell disease: a single institution experience. Pediatr Blood Cancer. 2019;66(Supplement 2):263. doi:10.1002/pbc.27713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.27713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rhodes MM, Adkins L, Anderews T, Thornton J, Jaggi P. Meningococcal vaccination in children with sickle cell disease: who is responsible?
Am J Hematol. 2012;87:E32–E33.</Citation>
        </Reference>
        <Reference>
          <Citation>Akingbola TS, Tayo BO, Salako B, Layden JE, Hsu LL, Cooper RS, Gordeuk VR, Saraf SL. Comparison of patients from Nigeria and the USA highlights modifiable risk factors for sickle cell anemia complications. Hemoglobin. 2014;38(4):236–43. doi:10.3109/03630269.2014.927363.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/03630269.2014.927363</ArticleId>
            <ArticleId IdType="pmc">PMC4161131</ArticleId>
            <ArticleId IdType="pubmed">24941131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meier ER, Brown L, Hampton K, Bloom E, Lawson D, Hall SA. A novel sickle cell outreach program improves access to TCD screening, vaccines and hydroxyurea in a medically underserved area. Blood. 2019;134(Supplement_1):4696. doi:10.1182/blood-2019-130209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1182/blood-2019-130209</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>BrousseV, Arnaud C, Lesprit E, Quinet B, Odièvre M-H,  Etienne-Julan M, Guillaumat C, Elana G, Belloy M, Garnier N, et al. Evaluation of outcomes and quality of care in children with sickle cell disease diagnosed by newborn screening: a real-world nation-wide study in France. J Clin Med. 2019;8(10):1594. doi:10.3390/jcm8101594.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/jcm8101594</ArticleId>
            <ArticleId IdType="pmc">PMC6832704</ArticleId>
            <ArticleId IdType="pubmed">31581727</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reeves SL, Jary HK, Gondhi JP, Kleyn M, Wagner AL, Dombkowski KJ. Pneumococcal vaccination coverage among children with sickle cell anemia, sickle cell trait, and normal hemoglobin. Pediatr Blood Cancer. 2018;65(10):e27282. doi:10.1002/pbc.27282.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.27282</ArticleId>
            <ArticleId IdType="pubmed">29905397</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colombatti R, Montanaro M, Guasti F, Rampazzo P, Meneghetti G, Giordan M, Basso G, Sainati L. Comprehensive care for sickle cell disease immigrant patients: a reproducible model achieving high adherence to minimum standards of care. Pediatr Blood Cancer. 2012;59(7):1275–79. doi:10.1002/pbc.24110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.24110</ArticleId>
            <ArticleId IdType="pubmed">22359409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie R, King L, Fraser R, Reid M. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening. Ann Trop Paediatr. 2009;29(3):197–202. doi:10.1179/027249309X12467994693851.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1179/027249309X12467994693851</ArticleId>
            <ArticleId IdType="pubmed">19689861</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meier ER, Janson IA, Hampton K, Bloom E, Duncan N, Roberson C, Rampersad A. Adherence to quality of care indicators and location of sickle cell care within Indiana. J Community Health. 2020;45(1):81–87. doi:10.1007/s10900-019-00721-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10900-019-00721-x</ArticleId>
            <ArticleId IdType="pubmed">31396825</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sobota AE, Kavanagh PL, Adams WG, McClure E, Farrell D, Sprinz PG. Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic. Pediatr Blood Cancer. 2015;62(4):654–57. doi:10.1002/pbc.25390.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pbc.25390</ArticleId>
            <ArticleId IdType="pmc">PMC5712840</ArticleId>
            <ArticleId IdType="pubmed">25545967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colombatti R, Perrotta S, Masera N, Palazzi G, Notarangelo LD, Pusiol A, Bonetto E, De Zen L, Nocerino A, Samperi P, et al. Lessons learned from the H1N1 pandemic: the need to improve systematic vaccination in sickle cell disease children. A multi center survey in Italy. Vaccine. 2011;29(6):1126–28. doi:10.1016/j.vaccine.2010.11.089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2010.11.089</ArticleId>
            <ArticleId IdType="pubmed">21147126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bailey A, Bandi S. G136(P) Immunisation of HIV positive children. Arch Dis Child. 2013;98(Suppl 1):A63–A63. doi:10.1136/archdischild-2013-304107.148.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2013-304107.148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Setse R, Cutts F, Monze M, Ryon J, Quinn T, Griffen D, Moss W. HIV-1 infection as a risk factor for incomplete childhood immunization in Zambia. J Trop Pediatr. 2006;52(5):324–28. doi:10.1093/tropej/fmk002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/tropej/fmk002</ArticleId>
            <ArticleId IdType="pubmed">16401614</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhesi A, Bandi S, Blake K, Welch S, Thompson M. Immunisation of children with HIV. Arch Dis Child. 2012;97(Suppl 1):A32. doi:10.1136/archdischild-2012-301885.82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/archdischild-2012-301885.82</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tchidjou HK, Vescio MF, Sanou Sobze M, Souleyman A, Stefanelli P, Mbabia A, Moussa I, Gentile B, Colizzi V, Rezza G, et al. Low vaccine coverage among children born to HIV infected women in Niamey, Niger. Hum Vaccines Immunother. 2016;12(2):540–44. doi:10.1080/21645515.2015.1069451.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/21645515.2015.1069451</ArticleId>
            <ArticleId IdType="pmc">PMC5049730</ArticleId>
            <ArticleId IdType="pubmed">26237156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Succi RCM, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Ruz NP, Pierre RB, Kolevic L, Joao E, et al. Undervaccination of perinatally HIV-Infected and HIV-Exposed uninfected children in Latin America and the Caribbean. Pediatr Infect Dis J. 2013;32(8):845–50. doi:10.1097/INF.0b013e31828bbe68.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e31828bbe68</ArticleId>
            <ArticleId IdType="pmc">PMC3717191</ArticleId>
            <ArticleId IdType="pubmed">23860480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Succi RCM, Krauss MR, Harris DR, Machado DM, de Moraes-Pinto MI, Mussi-Pinhata MM, Pavia Ruz N, Pierre RB, Kolevic Roca LA, Joao E, et al. Immunity after childhood vaccinations in perinatally HIV-exposed children with and without HIV infection in Latin America. Pediatr Infect Dis J. 2018;37(4):304–09. doi:10.1097/INF.0000000000001831.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0000000000001831</ArticleId>
            <ArticleId IdType="pmc">PMC5849487</ArticleId>
            <ArticleId IdType="pubmed">29140938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taha TE, Graham SM, Kumwenda NI, Broadhead RL, Hoover DR, Markakis D, van der Hoeven L, Liomba GN, Chiphangwi JD, Miotti PG, et al. Morbidity among Human Immunodeficiency Virus-1-Infected and -Uninfected African children. Pediatrics. 2000;106(6):e77–e77. doi:10.1542/peds.106.6.e77.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.106.6.e77</ArticleId>
            <ArticleId IdType="pubmed">11099620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pandolfi E, Carloni E, Marino MG, Ciofi degli Atti ML, Gesualdo F, Romano M, Giannattasio A, Guarino A, Carloni R, Borgia P, et al. Immunization coverage and timeliness of vaccination in Italian children with chronic diseases. Vaccine. 2012;30(34):5172–78. doi:10.1016/j.vaccine.2011.02.099.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.02.099</ArticleId>
            <ArticleId IdType="pubmed">21414380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giagnorio MG, Minicucci V, Mariano M, Romano R, Napolitano C, Manchisi M, Macchiaroli A, Vecchio AL, Raia V, Giannattasio A, et al. 177 Strategies to improve influenza vaccination coverage in at-risk children: the experience of patients with cystic fibrosis. J Cyst Fibros. 2013;12(Supplement 1):S93. doi:10.1016/s1569-1993(13)60318-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1569-1993(13)60318-5</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Welzel T, Zumbrunn T, Bonhoeffer J, Cannizzaro Schneider E, Hofer M, Kaiser D, Hentgen V, Woerner A. High vaccine coverage rates are not enough: vaccination delay and risk for vaccinepreventable diseases in pediatric patients with rheumatic diseases with and without immunosuppressive therapy. Swiss Med Wkly. 2018;184(Supplement 228):6S.</Citation>
        </Reference>
        <Reference>
          <Citation>Nicol S, Lawrence S, Jacobson K. Inadequate vaccination uptake in children receiving anti-TNF therapy for inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2017;64(Supplement 1):501. doi:10.1097/01.mpg.0000516381.25680.b4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mpg.0000516381.25680.b4</ArticleId>
            <ArticleId IdType="pubmed">0</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Franczak-Chmura P, Tomaszek MB, Sobiesiak A, Opoka-Winiarska V. The vaccination status of patients with juvenile idiopathic arthritis. Pediatr Rheumatol. 2018;16(Supplement 2):128. doi:10.1186/s12969-018-0265-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12969-018-0265-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sousa H, Carvalho S, Rodrigues M, Brito I, Reis P, Rocha T, Ramos M, Santos M, Ramos F, Cabral M, Guedes M. Vaccination coverage in Portuguese children with rheumatic diseases undergoing immunosuppressive therapy. Pediatr Rheumatol. 2018;16(Supplement 2):196–97. doi:10.1002/art.40466.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.40466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinelli M, Giugliano FP,  Miele E, Strisciuglio C, Urbonas V, Serban DE, Banaszkiewicz A, Assa A, Hojsak I, Lerchova T, et al. Vaccinations and immunization status in pediatric inflammatory bowel disease: a multicenter study from the pediatric IBD porto group of the ESPGHAN. Inflamm Bowel Dis. 2020;26(9):1407–14. doi:10.1093/ibd/izz264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ibd/izz264</ArticleId>
            <ArticleId IdType="pubmed">31689349</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cagol L, Seitel T, Ehrenberg S, Frivolt K, Krahl A, Lainka E, Gerner P, Lenhartz H, Vermehren J, Radke M, et al. Vaccination rate and immunity of children and adolescents with inflammatory bowel disease or autoimmune hepatitis in Germany. Vaccine. 2020;38(7):1810–17. doi:10.1016/j.vaccine.2019.12.024.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2019.12.024</ArticleId>
            <ArticleId IdType="pubmed">31879123</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feldon M, Furnier A, Lehmann C, Fletcher B, Kues J, Speer B, Kramer S, Morgan P, Siegle L, Brady R, et al. Improving pneumococcal immunization rates among immunocompromised adolescent patients at a tertiary care children’s hospital. Arthritis Rheumatol. 67(Supplement10):2015. http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed13&amp;NEWS=N&amp;AN=72094916.</Citation>
        </Reference>
        <Reference>
          <Citation>Temtem T, Whitworth J, Bagga B. Pneumococcal polysaccharide vaccination in pediatric inflammatory bowel disease. Glob Pediatr Heal. 2019;6(1):1–4. doi:10.1177/2333794x19849754.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2333794x19849754</ArticleId>
            <ArticleId IdType="pmc">PMC6537249</ArticleId>
            <ArticleId IdType="pubmed">31205985</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ayers M, Mahajan L, Anani A, Collyer E. Immunization rates for PPSV23 (pneumovax) in immunocompromised pediatric patients with inflammatory bowel disease: room for improvement. J Pediatr Gastroenterol Nutr. 2016;63:S76.</Citation>
        </Reference>
        <Reference>
          <Citation>Banaszkiewicz A, Klincewicz B, Lazowska-Przeorek I, Grzybowska-Chlebowczyk U, Kąkol P, Mytyk A, Kofla A, Radzikowski A. Influenza vaccination coverage in children with inflammatory bowel disease. Influenza Other Respi Viruses. 2014;8(4):431–35. doi:10.1111/irv.12236.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/irv.12236</ArticleId>
            <ArticleId IdType="pmc">PMC4181802</ArticleId>
            <ArticleId IdType="pubmed">24490714</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taylor J, Haddix EF, Badinghaus K, Burns M, Moore T, Ranz J, Anneken A, Fiorini P, Spiegel E, Morgan-Dewitt E, et al. Participation in hospital influenza collaborative is influential in improving vaccination rates in patients with juvenile idiopathic arthritis and systemic lupus erythematosus. Arthritis Rheum. 2011;63(Supplement 10):S616.</Citation>
        </Reference>
        <Reference>
          <Citation>Spijkerman R, Teuben MPJ, Hietbrink F, Kramer WLM, Leenen LPH. A cohort study to evaluate infection prevention protocol in pediatric trauma patients with blunt splenic injury in a Dutch level 1 trauma center. Patient Prefer Adherence. 2018;12:1607–17. doi:10.2147/PPA.S169072.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2147/PPA.S169072</ArticleId>
            <ArticleId IdType="pmc">PMC6118241</ArticleId>
            <ArticleId IdType="pubmed">30214163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khasawneh MA, Contreras-Peraza N, Hernandez MC, Lohse C, Jenkins DH, Zielinski MD. Outcomes after splenectomy in children: a 48-year population-based study. Pediatr Surg Int. 2019;35(5):575–82. doi:10.1007/s00383-019-04439-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00383-019-04439-8</ArticleId>
            <ArticleId IdType="pubmed">30712082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kind EA, Craft C, Fowles JB, McCoy CE. Pneumococcal vaccine administration associated with splenectomy: missed opportunities. Am J Infect Control. 1998;26(4):418–22. doi:10.1016/S0196-6553(98)70038-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0196-6553(98)70038-0</ArticleId>
            <ArticleId IdType="pubmed">9721395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berkhout A, Varghese V, Prasad V, Heussler H, Preece K, Clark J, Wen S. Optimising immunisations in children with 22Q11 microdeletion. J Paediatr Child Health. 2019;55(S2):15–15. doi:10.1111/jpc.14468.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jpc.14468</ArticleId>
            <ArticleId IdType="pmc">PMC7580130</ArticleId>
            <ArticleId IdType="pubmed">33150298</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tennis P, Toback SL, Andrews EB, McQuay LJ, Ambrose CS. A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season. Vaccine. 2012;30(42):6099–102. doi:10.1016/j.vaccine.2012.07.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2012.07.031</ArticleId>
            <ArticleId IdType="pubmed">22841479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajaram S, Steffey A, Blak B, Hickman M, Christensen H, Caspard H. Uptake of childhood influenza vaccine from 2012–2013 to 2014–2015 in the UK and the implications for high-risk children: a retrospective observational cohort study. BMJ Open. 2016;6(8):e010625. doi:10.1136/bmjopen-2015-010625.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2015-010625</ArticleId>
            <ArticleId IdType="pmc">PMC4985803</ArticleId>
            <ArticleId IdType="pubmed">27481618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sammon CJ, McGrogan A, Snowball J, De Vries CS. Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the general practice research database. Vaccine. 2012;30(14):2483–89. doi:10.1016/j.vaccine.2011.11.077.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.vaccine.2011.11.077</ArticleId>
            <ArticleId IdType="pubmed">22133511</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
